Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medlab Clinical (MDBBF)
OTHER OTC:MDBBF
Medlab Clinical (MDBBF) Stock Price & Analysis
2 Followers
MDBBF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.11 - $0.11
Previous Close$0.11
Volume2.00
Average Volume (3M)10.00K
Market Cap
$10.06M
Enterprise Value$7.12M
Total Cash (Recent Filing)AU$5.19M
Total Debt (Recent Filing)AU$1.12M
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Aug 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.15
Shares Outstanding2,283,502
10 Day Avg. Volume0
30 Day Avg. Volume10,000
Standard Deviation0.38
R-Squared0.12
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Medlab Clinical News
PremiumCompany Announcements
Medlab Clinical Posts Lower Losses, No Dividends
PremiumCompany Announcements
Medlab Clinical Advances Strategic Acquisition Plans
PremiumCompany Announcements
Medlab Clinical Shares Vital Shareholder Update
PremiumCompany Announcements
Medlab Clinical Reports Declining Revenues and LossesMDBBF FAQ
What was Medlab Clinical’s price range in the past 12 months?
Medlab Clinical lowest stock price was $0.10 and its highest was $0.10 in the past 12 months.
What is Medlab Clinical’s market cap?
Currently, no data Available
When is Medlab Clinical’s upcoming earnings report date?
Medlab Clinical’s upcoming earnings report date is Aug 30, 2024 which is in 38 days.
How were Medlab Clinical’s earnings last quarter?
Currently, no data Available
Is Medlab Clinical overvalued?
According to Wall Street analysts Medlab Clinical’s price is currently Overvalued.
Does Medlab Clinical pay dividends?
Medlab Clinical does not currently pay dividends.
What is Medlab Clinical’s EPS estimate?
Medlab Clinical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medlab Clinical have?
Medlab Clinical has 2,283,502 shares outstanding.
What happened to Medlab Clinical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Medlab Clinical?
Currently, no hedge funds are holding shares in MDBBF
---
Medlab Clinical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-302.81%
Trailing 12-Months
Asset Growth
-94.15%
Trailing 12-Months
Company Description
Medlab Clinical
Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.
---
Technical Analysis
---